SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-015493
Filing Date
2018-11-13
Accepted
2018-11-13 16:05:49
Documents
55
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0918_delmarpharma.htm 10-Q 456028
2 CERTIFICATION f10q0918ex31-1_delmarpharma.htm EX-31.1 9502
3 CERTIFICATION f10q0918ex31-2_delmarpharma.htm EX-31.2 9579
4 CERTIFICATION f10q0918ex32-1_delmarpharma.htm EX-32.1 3489
5 CERTIFICATION f10q0918ex32-2_delmarpharma.htm EX-32.2 3302
  Complete submission text file 0001213900-18-015493.txt   3404689

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE dmpi-20180930.xml EX-101.INS 685404
7 XBRL SCHEMA FILE dmpi-20180930.xsd EX-101.SCH 45762
8 XBRL CALCULATION FILE dmpi-20180930_cal.xml EX-101.CAL 23982
9 XBRL DEFINITION FILE dmpi-20180930_def.xml EX-101.DEF 178224
10 XBRL LABEL FILE dmpi-20180930_lab.xml EX-101.LAB 351861
11 XBRL PRESENTATION FILE dmpi-20180930_pre.xml EX-101.PRE 254075
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 181177935
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1